Dyne Therapeutics, Inc. DYN Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s total liabilities?
- Dyne Therapeutics, Inc. (DYN) reported total liabilities of $214.9M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s total liabilities changed year-over-year?
- Dyne Therapeutics, Inc.'s total liabilities increased by 312.5% year-over-year, from $52.1M to $214.9M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s total liabilities has grown at a 81.3% compound annual growth rate (CAGR), from $10.97M to $214.83M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.